NCT05266794View on ClinicalTrials.gov

A Novel Role of Alpha Lipoic Acid in Comparison With Selenium in Mitochondrial Resuscitation and miRNA-126 Expression in Hemodialysis Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

January 22, 2019

Primary Completion Date

April 23, 2019

Study Completion Date

April 30, 2019

Conditions
Antioxidative StressEnd Stage Renal Disease on Dialysis
Interventions
DRUG

Alpha lipoic acid

20 patients who received Alpha Lipoic acid (ALA) (Thiotex fort®) 600mg once daily with their routine therapy just after the dialysis sessions for 3 months.

DRUG

Selenium

23 patients who received Selenium 200µg once daily with their routine therapy just a

Trial Locations (1)

11566

Ain Shams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT05266794 - A Novel Role of Alpha Lipoic Acid in Comparison With Selenium in Mitochondrial Resuscitation and miRNA-126 Expression in Hemodialysis Patients | Biotech Hunter | Biotech Hunter